Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.
about
25-hydroxyvitamin D levels and the risk of mortality in the general populationAre there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysisLanthanum carbonate: safety data after 10 yearsLow plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysisThe Value of the Model and Quantitative Parameters of Contrast-Enhanced Ultrasound in Judging the Severity of SHPT.Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysisObservational studies versus randomized controlled trials: avenues to causal inference in nephrology.Impact of new vitamin D data on future studies and treatment.Vitamin D in Chronic Kidney Disease and Dialysis Patients.Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012.Clinical measures identify vitamin D deficiency in dialysis.Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.Calcium balance and negative impact of calcium load in peritoneal dialysis patients.Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?Serum alkaline phosphatase and phosphate and risk of mortality and hospitalizationAnalysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients.Vitamin D and glucose metabolism in chronic kidney disease.Fibroblast growth factor 23 and mortality among patients undergoing hemodialysisInteractions between adrenal-regulatory and calcium-regulatory hormones in human health.Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients.A review of the reporting and handling of missing data in cohort studies with repeated assessment of exposure measures.Mineral and bone disorder in Chinese dialysis patients: a multicenter study.The noncalciotropic actions of vitamin D: recent clinical developments.Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China.Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis.Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysisOral active vitamin d treatment and mortality in maintenance hemodialysis patients.Clinical Significance of FGF-23 in Patients with CKD.Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies.Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa Heart Study)Osteo-renal regulation of systemic phosphate metabolism.Improved long-term survival of dialysis patients after near-total parathyroidectomy.An optical method for serum calcium and phosphorus level assessment during hemodialysisSafety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysisAnalysis of Adequacy of 25-Hydroxi vitamin D3 Supplementation in Patients on Hemodialysis and Parathormone, Calcium and Phosphorus Level in the Blood of These PatientsThe use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism.Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients.
P2860
Q24650811-2385D290-3CFA-4532-BA21-0636D3D041E6Q27002431-39F86A69-A7F4-4F5B-B7C7-7327FD8E49DBQ27011288-CB1B5610-D6BD-47D7-B24B-587A46D59164Q28079982-6ECBFB3E-C1CD-49CF-904B-6950E05990B7Q28306312-DD41CDE8-C4C9-46DE-97BA-9B97B8B0C933Q30365852-8AFF4BFE-3BC0-4BC6-809D-A4ED1FE163D7Q30408489-A93DD571-A394-45BC-A446-A00A2D40545AQ30423049-D2E2A6A6-EE31-42A0-B1FC-E7953356AE29Q30624696-2B6F5A25-3326-4486-9133-20BE0AD8C13AQ33616582-A25BFB07-BDB1-431F-8F69-11B8452AE4C7Q33671574-9BE4F170-89B5-462A-9B59-001B54BBA8C3Q33684038-95E49C88-0747-4028-BF68-6C37198146CDQ33770086-48BD3251-4058-47F0-AE9B-AD166CB232DFQ33837633-0EAD0B1F-41B2-4BB9-9E17-0FAD3B527DA5Q33859007-A65E7FE6-9CCA-4400-978F-9E5173E2AC53Q33862710-9BD4A79D-021C-417A-AC39-0CD69E084437Q33880308-EBF02F06-6CEE-40EF-891E-76EDAB0ED3CAQ33888428-FA1211DA-607A-4923-8D40-5046D1485DFFQ33890218-F8D3630E-EDC5-4B28-A3A7-6A0EE59F15F7Q33899041-F81FBCA5-E1F3-4223-A0EE-7235BB0AB654Q33932297-3A076521-AED4-42B9-8164-F761648A8FBFQ34008136-3DEC3341-01EE-4F87-A86D-2EEA385EAD78Q34135288-D2ACC280-E474-4B0A-85F3-E46785E77514Q34333257-8574FCBA-F794-4127-9A3D-2C3A0635C590Q34418538-3A40E752-7D45-427A-9888-1C11EE4E523FQ34532994-7FFFFAE6-5253-40D7-819D-0716E281F619Q34573734-C8FC1A64-2B9A-4776-AA60-D9AA23F27326Q34610602-0898B19D-7A82-48C0-9E34-6CB3918EE1B4Q34857892-1A77F5D0-BA2C-485A-B272-EB3B36D15999Q34985742-DE47F054-AB8C-4198-9245-E2835355FE6EQ34989319-313AEDA6-971F-4D24-82FD-506D3932E0E1Q34997739-F7B37EB0-40CC-4BDA-9E55-FBA01BCF9F9CQ35010606-1C2E95F4-3250-44C9-AA0E-9D2EE136F5FFQ35059741-B8EFB9F4-9850-48B0-B038-EEA9B038F3C7Q35146504-BD372CE5-A5C1-4B67-8A31-205EBC6E969BQ35232708-F5316CDE-0521-42AC-AE5F-DF1E118CE275Q35351243-EB97742C-935C-4D35-90B4-84191354DABFQ35507936-0F4873B2-0A2C-4C1E-AE68-FE4D71277C92Q35573698-DAC6093E-BD53-43E3-A9F4-00D45508836CQ35573785-1901F735-166A-44DE-A78F-D58EBA418CAA
P2860
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Changes in serum calcium, phos ...... atients: a longitudinal study.
@en
Changes in serum calcium, phos ...... atients: a longitudinal study.
@nl
type
label
Changes in serum calcium, phos ...... atients: a longitudinal study.
@en
Changes in serum calcium, phos ...... atients: a longitudinal study.
@nl
prefLabel
Changes in serum calcium, phos ...... atients: a longitudinal study.
@en
Changes in serum calcium, phos ...... atients: a longitudinal study.
@nl
P2093
P356
P1433
P1476
Changes in serum calcium, phos ...... atients: a longitudinal study.
@en
P2093
Eustace JA
Melamed ML
Plantinga L
P2888
P304
P356
10.1038/SJ.KI.5001542
P407
P577
2006-05-31T00:00:00Z